A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis

Clinical trial NCT03765788 · COMPLETED

Trial details

NCT number: NCT03765788
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Giant Cell Arteritis

Start date: 2019-01-30
Primary completion: 2021-06-08
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.